美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=EFAVIRENZ"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
EFAVIRENZ 077916 001 ANDA EFAVIRENZ TABLET; ORAL 600MG No 2006/05/24 (TA) CIPLA LIMITED None (Tentative Approval)
EFAVIRENZ 078509 001 ANDA EFAVIRENZ TABLET; ORAL 600MG No 2007/03/26 (TA) STRIDES INC None (Tentative Approval)
LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ 022096 001 NDA LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ TABLET; ORAL 150MG; 300MG; 600MG No 2007/06/01 (TA) STRIDES ACROLAB None (Tentative Approval)
STAVUDINE; LAMIVUDINE; EFAVIRENZ 022097 001 NDA STAVUDINE; LAMIVUDINE; EFAVIRENZ TABLET; ORAL 40MG; 150MG; 600MG No 2007/06/01 (TA) STRIDES ACROLAB None (Tentative Approval)
EFAVIRENZ 078958 001 ANDA EFAVIRENZ TABLET; ORAL 600MG No 2007/12/20 (TA) EMCURE PHARMA None (Tentative Approval)
EFAVIRENZ 078883 001 ANDA EFAVIRENZ TABLET; ORAL 600MG No 2008/04/25 (TA) MATRIX LABS None (Tentative Approval)
EFAVIRENZ 090155 001 ANDA EFAVIRENZ CAPSULE; ORAL 200MG No 2009/08/03 (TA) CIPLA LIMITED None (Tentative Approval)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 090437 001 ANDA EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 600MG; 200MG; 300MG No 2009/08/12 (TA) MATRIX LABS LTD None (Tentative Approval)
EFAVIRENZ 022461 001 NDA EFAVIRENZ TABLET; ORAL 50MG No 2009/11/24 (TA) MATRIX LABS LTD None (Tentative Approval)
EFAVIRENZ 022461 002 NDA EFAVIRENZ TABLET; ORAL 100MG No 2009/11/24 (TA) MATRIX LABS LTD None (Tentative Approval)
EFAVIRENZ 022461 003 NDA EFAVIRENZ TABLET; ORAL 200MG No 2009/11/24 (TA) MATRIX LABS LTD None (Tentative Approval)
EFAVIRENZ 200MG SCORED TABLETS 022420 001 NDA EFAVIRENZ TABLET; ORAL 200MG No 2010/02/12 (TA) STRIDES ARCOLAB LTD None (Tentative Approval)
EFAVIRENZ 091579 001 ANDA EFAVIRENZ TABLET; ORAL 600MG No 2011/08/29 (TA) MACLEODS PHARMS LTD None (Tentative Approval)
EFAVIRENZ 202042 001 ANDA EFAVIRENZ CAPSULE; ORAL 50MG No 2012/01/19 (TA) MICRO LABS LTD None (Tentative Approval)
EFAVIRENZ 202042 002 ANDA EFAVIRENZ CAPSULE; ORAL 200MG No 2012/01/19 (TA) MICRO LABS LTD None (Tentative Approval)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 091593 001 ANDA EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 600MG No 2012/02/27 (TA) CIPLA LIMITED None (Tentative Approval)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 091593 002 ANDA EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 200MG No 2012/02/27 (TA) CIPLA LIMITED None (Tentative Approval)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 091593 003 ANDA EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 300MG No 2012/02/27 (TA) CIPLA LIMITED None (Tentative Approval)
EFAVIRENZ 202301 001 ANDA EFAVIRENZ TABLET; ORAL 600MG No 2012/06/20 (TA) MICRO LABS LTD None (Tentative Approval)
EFAVIRENZ 202990 001 ANDA EFAVIRENZ TABLET; ORAL 600MG No 2012/06/25 (TA) PAR FORMULATIONS PRIVATE LTD None (Tentative Approval)
药品名称,活性成分,申请号搜索 高级检索
©2006-2019 DrugFuture->U.S. FDA Drugs Database